EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole



Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole



Journal of Reproductive Medicine 39(7): 517-520



In a randomized study, 151 women with a history of recurrent vulvovaginal candidiasis and suffering from an acute episode of candidal vaginitis were assigned to receive either oral ketoconazole, 400 mg daily for 14 days, or clotrimazole vaginal suppositories, 100 mg daily for 7 days. One week after completion of therapy, evaluation revealed a clinical cure or improvement in 86.4% of ketoconazole- and 81.7% of clotrimazole-treated patients (P > .5), with a mycologic response in 80.3% and 81.7%, respectively. In the absence of maintenance suppressive antimycotic therapy, further follow-up for two months revealed an extremely high rate of clinical and mycologic failure in both groups, reaching 52.5% after ketoconazole and 62.6% after clotrimazole (NS). Adverse effects were significantly more common with systemic ketoconazole than accompanying topical clotrimazole therapy. Although both forms of antifungal therapy were highly successful in inducing clinical and mycologic remission in patients with recurrent vulvovaginal candidiasis, this study emphasized the need for immediate initiation of maintenance therapy following an initial clinical improvement.

(PDF emailed within 1 workday: $29.90)

Accession: 002641130

Download citation: RISBibTeXText

PMID: 7966041



Related references

Comparison of topical clotrimazole, oral fluconazole and oral itraconazole in acute vulvovaginal candidiasis. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 274, 1993

Management of recurrent vulvovaginal candidiasis with ketoconazole prophylaxis. Archives of Gynecology 237(SUPPL): 281, 1985

Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstetrics and Gynecology 65(3): 435-440, 1985

Double blind comparison of the efficacy and safety of single dose intravaginal treatment with clotrimazole and five days oral treatment with ketoconazole in vulvovaginal candidiasis. Archives Of Gynecologyuppl: 62, 1985

Single dose topical treatment of vulvovaginal candidiasis with a new 500 milligram clotrimazole vaginal tablet. Advances in Therapy 1(2): 137-145, 1984

Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology 184(4): 598-602, 2001

Fluconazole versus 3-day clotrimazole in the treatment of sporadic and recurrent vulvovaginal candidiasis. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 95(2): 171-172, 2006

Recurrent and persistent vulvovaginal candidiasis: treatment with ketoconazole. Obstetrics and Gynecology 66(2): 248-254, 1985

Comparison of ketoconazole prophylactic regimens for treatment of recurrent vulvovaginal candidiasis. Iwata, K And H Vanden Bossche (Ed ) in Vitro And in Vivo Evaluation Of Antifungal Agents; International Symposium, Tokyo, Japan, June 19-22, 1985 Xv+305p Elsevier Science Publishers: Amsterdam, Netherlands; New York, New York, Usa (Dist For The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus 241-246, 1986

Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy. New England Journal of Medicine 315(23): 1455-1458, 1986

The efficacy and safety of clotrimazole vaginal tablet vs. oral fluconazole in treating severe vulvovaginal candidiasis. Mycoses 59(7): 419-428, 2016

Oral fluconazole 150 mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. Journal of Infection and Public Health 4(4): 195-199, 2012

Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis. American Journal of Obstetrics and Gynecology 152(7 Pt 2): 965-968, 1985

A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana. Medical Mycology 55(6): 686-689, 2016

Oral fluconazole 15mg single dose versus intra-vaginal clotrimazole treatment of acute vulvovaginal candidiasis. 2011